Universal Biosensors, Inc. (UBI.AX)
AUD 0.06
(-1.56%)
AUD 0.06
(-1.56%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -9.09 Million AUD | 1.63% |
| 2022 | -31.65 Million AUD | -83.62% |
| 2021 | -11.71 Million AUD | -21.94% |
| 2020 | -7.87 Million AUD | 27.14% |
| 2019 | -7.45 Million AUD | -120.13% |
| 2018 | 48.53 Million AUD | 1327.06% |
| 2017 | 3.6 Million AUD | -17.94% |
| 2016 | -1.07 Million AUD | 149.4% |
| 2015 | -8.4 Million AUD | -26.35% |
| 2014 | -14.07 Million AUD | 38.47% |
| 2013 | -8.31 Million AUD | -18.81% |
| 2012 | -6.49 Million AUD | 40.8% |
| 2011 | -11.39 Million AUD | -97.03% |
| 2010 | -3.61 Million AUD | -641.87% |
| 2009 | 4.29 Million AUD | 112.01% |
| 2008 | -9.71 Million AUD | 1.78% |
| 2007 | -8.24 Million AUD | -273.18% |
| 2006 | -3.27 Million AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -3.4 Million AUD | 11.65% |
| 2024 Q2 | -4.25 Million AUD | -29.95% |
| 2024 Q3 | -3.66 Million AUD | 23.93% |
| 2023 FY | - AUD | 1.63% |
| 2023 Q2 | 1.66 Million AUD | 146.74% |
| 2023 Q1 | -3.55 Million AUD | 11.64% |
| 2023 Q3 | -2.31 Million AUD | -239.3% |
| 2023 Q4 | -3.7 Million AUD | -60.19% |
| 2022 Q3 | -4.34 Million AUD | -15.57% |
| 2022 Q4 | -4.02 Million AUD | 7.52% |
| 2022 FY | - AUD | -83.62% |
| 2022 Q1 | -3.83 Million AUD | -4.03% |
| 2022 Q2 | -3.76 Million AUD | 1.87% |
| 2021 Q1 | -1.25 Million AUD | -41.25% |
| 2021 Q3 | -2.34 Million AUD | -66.14% |
| 2021 Q4 | -3.68 Million AUD | -57.38% |
| 2021 Q2 | -1.41 Million AUD | -12.07% |
| 2021 FY | - AUD | -21.94% |
| 2020 Q2 | -1.73 Million AUD | 31.69% |
| 2020 Q3 | -1.37 Million AUD | 20.34% |
| 2020 FY | - AUD | 27.14% |
| 2020 Q1 | -2.53 Million AUD | -37.71% |
| 2020 Q4 | -890.74 Thousand AUD | 35.38% |
| 2019 Q3 | -1.41 Million AUD | -15.16% |
| 2019 FY | - AUD | -120.13% |
| 2019 Q4 | -1.83 Million AUD | -30.12% |
| 2019 Q2 | -1.22 Million AUD | 36.0% |
| 2019 Q1 | -1.91 Million AUD | -146.61% |
| 2018 FY | - AUD | 1327.06% |
| 2018 Q4 | 4.11 Million AUD | -90.38% |
| 2018 Q3 | 42.78 Million AUD | 11610.97% |
| 2018 Q2 | 365.32 Thousand AUD | -69.63% |
| 2018 Q1 | 1.2 Million AUD | 242.79% |
| 2017 Q4 | -842.58 Thousand AUD | -47.83% |
| 2017 FY | - AUD | -17.94% |
| 2017 Q1 | 2.86 Million AUD | 453.16% |
| 2017 Q2 | 289.85 Thousand AUD | -89.89% |
| 2017 Q3 | -569.95 Thousand AUD | -296.64% |
| 2016 Q1 | -1.62 Million AUD | -35.43% |
| 2016 FY | - AUD | 149.4% |
| 2016 Q3 | -2.07 Million AUD | -381.09% |
| 2016 Q2 | 738.02 Thousand AUD | 145.39% |
| 2016 Q4 | -812.11 Thousand AUD | 60.85% |
| 2015 Q2 | -3.26 Million AUD | 18.2% |
| 2015 Q4 | -1.2 Million AUD | -160.19% |
| 2015 Q3 | -461.47 Thousand AUD | 85.87% |
| 2015 Q1 | -3.99 Million AUD | -196.12% |
| 2015 FY | - AUD | -26.35% |
| 2014 Q1 | -5.56 Million AUD | -43.08% |
| 2014 FY | - AUD | 38.47% |
| 2014 Q4 | -1.34 Million AUD | 69.29% |
| 2014 Q3 | -4.39 Million AUD | 5.05% |
| 2014 Q2 | -4.62 Million AUD | 16.92% |
| 2013 Q2 | -3.79 Million AUD | 17.43% |
| 2013 Q1 | -4.59 Million AUD | -17.17% |
| 2013 FY | - AUD | -18.81% |
| 2013 Q4 | -3.88 Million AUD | 10.28% |
| 2013 Q3 | -4.33 Million AUD | -14.38% |
| 2012 Q3 | -497.23 Thousand AUD | 45.74% |
| 2012 FY | - AUD | 40.8% |
| 2012 Q2 | -916.35 Thousand AUD | 60.47% |
| 2012 Q1 | -2.31 Million AUD | 0.0% |
| 2012 Q4 | -3.91 Million AUD | -687.94% |
| 2011 Q1 | -2.91 Million AUD | 0.0% |
| 2011 FY | - AUD | -97.03% |
| 2011 Q3 | -4.14 Million AUD | 10.7% |
| 2011 Q2 | -4.63 Million AUD | -58.87% |
| 2010 Q1 | -1.08 Million AUD | 0.0% |
| 2010 Q3 | -693.34 Thousand AUD | 74.14% |
| 2010 Q2 | -2.68 Million AUD | -147.02% |
| 2010 FY | - AUD | -641.87% |
| 2009 Q3 | -4.01 Million AUD | 14.44% |
| 2009 FY | - AUD | 112.01% |
| 2009 Q2 | -4.69 Million AUD | -102.54% |
| 2009 Q1 | -2.31 Million AUD | 0.0% |
| 2008 FY | - AUD | 1.78% |
| 2007 FY | - AUD | -273.18% |
| 2006 FY | - AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| 4DMedical Limited | -36.06 Million AUD | 74.796% |
| Adherium Limited | -11.56 Million AUD | 21.393% |
| Aroa Biosurgery Limited | -7.36 Million AUD | -23.51% |
| Atomo Diagnostics Limited | -5.42 Million AUD | -67.612% |
| Anteris Technologies Ltd | -66.9 Million AUD | 86.413% |
| Control Bionics Limited | -5.15 Million AUD | -76.232% |
| CardieX Limited | -6.71 Million AUD | -35.439% |
| Compumedics Limited | 2.78 Million AUD | 425.939% |
| Cochlear Limited | 579.5 Million AUD | 101.569% |
| CleanSpace Holdings Limited | -3.49 Million AUD | -160.336% |
| Cyclopharm Limited | -3.03 Million AUD | -199.53% |
| EMVision Medical Devices Ltd | -2.09 Million AUD | -334.698% |
| Nova Eye Medical Limited | -5.97 Million AUD | -52.039% |
| HeraMED Limited | -3.97 Million AUD | -128.859% |
| Imricor Medical Systems, Inc. | -21.87 Million AUD | 58.435% |
| ImpediMed Limited | -22.05 Million AUD | 58.775% |
| InhaleRx Limited | -1.41 Million AUD | -543.005% |
| LBT Innovations Limited | -4.04 Million AUD | -124.511% |
| Micro-X Limited | -14.35 Million AUD | 36.656% |
| Neurotech International Limited | -8.24 Million AUD | -10.267% |
| OncoSil Medical Limited | -11.97 Million AUD | 24.096% |
| PolyNovo Limited | 5.17 Million AUD | 275.83% |
| Respiri Limited | -7.04 Million AUD | -28.944% |
| SomnoMed Limited | -2.32 Million AUD | -290.38% |
| Uscom Limited | -1.5 Million AUD | -502.291% |
| Visioneering Technologies, Inc. | -4.91 Million AUD | -84.863% |